Aurobindo Pharma's French unit Arrow Generiques to acquire select assets in France from Teva

India Infoline News Service | Mumbai | November 25, 2016 17:51 IST

The transaction is subject to the approval of the European Commission. Following receipt of clearances from European authorities, Arrow Generiques will integrate these products with its existing commercial operations in France, and focus on maximising their potential.

Arrow Generiques SAS, the French subsidiary of Aurobindo Pharma Ltd, today announced the signing of an agreement to acquire select commercial products in France from Teva. Arrow Generiques will acquire the right, title and interest in products Calcium and Calcium Vitamin D3, including the use of the OROCAL trademark.

The transaction is subject to the approval of the European Commission. Following receipt of clearances from European authorities, Arrow Generiques will integrate these products with its existing commercial operations in France, and focus on maximizing their potential. Arrow Generiques and Teva intend to ensure continuity of the supply of the products to the market.

This acquisition will enable Arrow Generiques to continue to increase its branded products portfolio and leverage its position as a key player in the drug market.

Arrow Generiques is a pharmaceutical company with focus on selling generics on the retail and hospital markets in France since 2002. Arrow Generiques entered a strategy of diversification with the acquisition of the first branded products a few years ago to become a company balanced between generics / branded products / biosimilars on retail and hospital market.

A dedicated Business Unit with sales and marketing team had been set up to specifically enhance this business. Arrow Generiques has continued developing the brand awareness among prescribers through the promotion of mature products and the launch of specialties for patients care.

The achievement of the Medical Visit Certification confirms the company's strategy in medical promotion. This deal will boost the position of Arrow Generiques and open new opportunities for the future.

***Note: This is a NSE Chart

 

Advertisements

  • Get your free IIFL Demat & Trading A/c now...Click here
  • Get IIFL express personal loan disbursal in just 8* hours...Know More
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.